Edition:
India

Evoke Pharma Reports Q1 Loss Per Share $0.11


Thursday, 9 May 2019 

May 8 (Reuters) - Evoke Pharma Inc ::EVOKE PHARMA REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.11.AS OF MARCH 31, 2019, COMPANY'S CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $4.0 MILLION.EVOKE PHARMA - BASED ON CURRENT OPERATING PLAN, CO'S EXISTING CASH AND CASH EQUIVALENTS, BELIEVE, WILL BE SUFFICIENT TO FUND OPERATIONS INTO Q1 2020. 

Company Quote

0.951
0.001 +0.11%
20 Sep 2019